RhumbLine Advisers’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$536K Buy
84,025
+75,294
+862% +$480K ﹤0.01% 2648
2025
Q1
$42.4K Sell
8,731
-1,508
-15% -$7.33K ﹤0.01% 3608
2024
Q4
$97.9K Sell
10,239
-2,011
-16% -$19.2K ﹤0.01% 3479
2024
Q3
$102K Sell
12,250
-5,374
-30% -$44.9K ﹤0.01% 3489
2024
Q2
$120K Sell
17,624
-69,920
-80% -$477K ﹤0.01% 3461
2024
Q1
$221K Buy
87,544
+2,242
+3% +$5.67K ﹤0.01% 3123
2023
Q4
$205K Buy
85,302
+2,166
+3% +$5.2K ﹤0.01% 3176
2023
Q3
$283K Sell
83,136
-77,626
-48% -$264K ﹤0.01% 2961
2023
Q2
$1.18M Buy
160,762
+2,406
+2% +$17.7K ﹤0.01% 2200
2023
Q1
$1.64M Buy
158,356
+7,191
+5% +$74.5K ﹤0.01% 1908
2022
Q4
$1.79M Buy
151,165
+439
+0.3% +$5.18K ﹤0.01% 1841
2022
Q3
$3.16M Buy
150,726
+5,126
+4% +$108K ﹤0.01% 1505
2022
Q2
$4.52M Buy
145,600
+2,934
+2% +$91.1K 0.01% 1292
2022
Q1
$5.86M Buy
142,666
+1,515
+1% +$62.2K 0.01% 1215
2021
Q4
$6.14M Sell
141,151
-7,852
-5% -$341K 0.01% 1246
2021
Q3
$7.46M Buy
149,003
+4,333
+3% +$217K 0.01% 1117
2021
Q2
$9.11M Buy
144,670
+20,617
+17% +$1.3M 0.01% 1066
2021
Q1
$11.5M Sell
124,053
-6,136
-5% -$570K 0.02% 901
2020
Q4
$11.7M Buy
130,189
+3,290
+3% +$295K 0.02% 833
2020
Q3
$13.1M Sell
126,899
-13,013
-9% -$1.34M 0.02% 645
2020
Q2
$11.1M Sell
139,912
-6,602
-5% -$522K 0.02% 724
2020
Q1
$8.48M Buy
146,514
+905
+0.6% +$52.4K 0.02% 734
2019
Q4
$7.86M Buy
145,609
+8,822
+6% +$476K 0.01% 984
2019
Q3
$7.15M Buy
136,787
+775
+0.6% +$40.5K 0.01% 977
2019
Q2
$6.57M Buy
136,012
+4,126
+3% +$199K 0.01% 1043
2019
Q1
$6.66M Buy
131,886
+3,131
+2% +$158K 0.01% 1012
2018
Q4
$7.63M Buy
128,755
+24,354
+23% +$1.44M 0.02% 855
2018
Q3
$6.87M Buy
104,401
+8,844
+9% +$582K 0.01% 902
2018
Q2
$4.83M Buy
95,557
+11,877
+14% +$600K 0.01% 1121
2018
Q1
$4.41M Buy
83,680
+1,452
+2% +$76.5K 0.01% 1122
2017
Q4
$3.82M Buy
82,228
+11,399
+16% +$530K 0.01% 1235
2017
Q3
$2.87M Buy
70,829
+1,825
+3% +$73.8K 0.01% 1372
2017
Q2
$2.34M Buy
69,004
+1,262
+2% +$42.8K 0.01% 1483
2017
Q1
$1.97M Buy
67,742
+19,253
+40% +$559K ﹤0.01% 1562
2016
Q4
$1.59M Buy
48,489
+2,034
+4% +$66.8K ﹤0.01% 1587
2016
Q3
$1.47M Buy
46,455
+4,163
+10% +$131K ﹤0.01% 1605
2016
Q2
$1.19M Sell
42,292
-732
-2% -$20.6K ﹤0.01% 1675
2016
Q1
$1.56M Buy
43,024
+1,125
+3% +$40.9K ﹤0.01% 1531
2015
Q4
$1.68M Buy
41,899
+2,505
+6% +$100K 0.01% 1469
2015
Q3
$1.12M Buy
39,394
+1,458
+4% +$41.5K ﹤0.01% 1697
2015
Q2
$1.25M Sell
37,936
-6,475
-15% -$213K ﹤0.01% 1722
2015
Q1
$1.28M Sell
44,411
-50
-0.1% -$1.44K ﹤0.01% 1709
2014
Q4
$1.21M Buy
44,461
+2,025
+5% +$55.2K ﹤0.01% 1680
2014
Q3
$904K Buy
42,436
+200
+0.5% +$4.26K ﹤0.01% 1827
2014
Q2
$949K Buy
42,236
+1,268
+3% +$28.5K ﹤0.01% 1854
2014
Q1
$1.04M Sell
40,968
-1,090
-3% -$27.5K ﹤0.01% 1777
2013
Q4
$967K Sell
42,058
-1,900
-4% -$43.7K ﹤0.01% 1835
2013
Q3
$837K Buy
43,958
+2
+0% +$38 ﹤0.01% 1892
2013
Q2
$634K Buy
+43,956
New +$634K ﹤0.01% 2087